Advances in the treatment of Hodgkin lymphoma: Current and future approaches

por Ullah, Fauzia, Dima, Danai, Omar, Najiullah, Ogbue, Olisaemeka, Ahmed, Sairah
Publicado 2023

Reappraising the Role of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Lymphoma: Recent Advances and Outcomes

por Al-Juhaishi, Taha, Borogovac, Azra, Ibrahimi, Sami, Wieduwilt, Matthew, Ahmed, Sairah
Publicado 2022

Differential Impact of a Multicomponent Goals-of-Care Program in Patients with Hematologic and Solid Malignancies

por Hui, David, Ahmed, Sairah, Nortje, Nico, George, Marina, Andersen, Clark R., Wilson, Kaycee, Urbauer, Diana, Flowers, Christopher, Bruera, Eduardo
Publicado 2023

Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder

por Markouli, Mariam, Ullah, Fauzia, Omar, Najiullah, Apostolopoulou, Anna, Dhillon, Puneet, Diamantopoulos, Panagiotis, Dower, Joshua, Gurnari, Carmelo, Ahmed, Sairah, Dima, Danai
Publicado 2022

Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy

por Fang, Penny Q., Gunther, Jillian R., Wu, Susan Y., Dabaja, Bouthaina S., Nastoupil, Loretta J., Ahmed, Sairah, Neelapu, Sattva S., Pinnix, Chelsea C.
Publicado 2021

Successful Treatment of Intracranial Hemorrhage with Recombinant Activated Factor VII in a Patient with Newly Diagnosed Acute Myeloid Leukemia: A Case Report and Review of the Lite...

por Pemmaraju, Naveen, Sasaki, Koji, Johnson, Daniel, Daver, Naval, Afshar-Kharghan, Vahid, Chen, Merry, Ahmed, Sairah, Colen, Rivka R., Kwon, Michael, Huh, Yang, Borthakur, Gautam
Publicado 2015

P103: Comparison of PET-derived parameters in program cell death-1 inhibitor and CD30 antibody drug conjugate-based therapies in patients with advanced stage cHL: A single center e...

por Kamel, Serageldin, Martiniova, Lucia, Aboismail, Eslam, Schmidt, Joo, Ahmed, Sairah, Nair, Ranjit, Steiner, Raphael E., Wang, Michael L., Soebianto, Sarita, Ravizzini, Gregory, Pan, Tinsu, Lee, Hun Ju
Publicado 2022

Nosocomial COVID-19 at a comprehensive cancer center during the first year of the pandemic: Lessons learned

por Khawaja, Fareed, Srinivasan, Krithika, Spallone, Amy, Feldman, Adina, Cantu, Sherry, Ariza-Heredia, Ella, Dvordak, Tanya, Alousi, Amin, Ahmed, Sairah, George, Marina, Frenzel, Elizabeth, Bhatti, Micah, Chemaly, Roy F
Publicado 2023

Prediction of Mortality Following Cytokine Storm in Patients with Hematological Malignancies and COVID-19 Infections

por Prakash, Rishab, Long, James, Edelkamp, Paul, Knafl, Mark, Ahmed, Sairah, Khawaja, Fareed, Nastoupil, Loretta J., Manzano, Joanna-Grace, Mulanovich, Victor, Prabhakaran, Sabitha, Futreal, Andrew, Woodman, Scott E, Iyer, Swaminathan Padmanabhan
Publicado 2022

ASCT vs CART for patients with relapsed LBCL in PR: role of TMTV

por Strati, Paolo, Pasvolsky, Oren, Feng, Lei, Xu, Guofan, Tewari, Sanjit O., Varghese, Jaimole, Ow, Karla, Santiago, Minifrida, Al Zaki, Ajlan, Jallouk, Andrew, Neelapu, Sattva S., Kebriaei, Partow, Shpall, Elizabeth J., Ahmed, Sairah
Publicado 2023

Adjunct Therapy with T Regulatory Cells Decreases Inflammation and Preserves the Anti-Tumor Activity of CAR T Cells

por Zeng, Ke, Huang, Meixian, Lyu, Mi-Ae, Khoury, Joseph D., Ahmed, Sairah, Patel, Krina K., Dropulić, Boro, Reese-Koc, Jane, Caimi, Paolo F., Sadeghi, Tara, de Lima, Marcos, Flowers, Christopher R., Parmar, Simrit
Publicado 2023

Partial omission of bleomycin for early‐stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?

por Gunther, Jillian R., Pinnix, Chelsea C., Glober, Gordon R., Christopherson, Kaitlin M., Fang, Penny, Lee, Hun Ju, Ahmed, Sairah, Steiner, Raphael E., Nair, Ranjit, Strati, Paolo, Neelapu, Sattva S., Nastoupil, Loretta J., Dabaja, Bouthaina S.
Publicado 2020

Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma

por Epperla, Narendranath, Ahn, Kwang Woo, Ahmed, Sairah, Jagasia, Madan, DiGilio, Alyssa, Devine, Steven M., Jaglowski, Samantha, Kennedy, Vanessa, Rezvani, Andrew R., Smith, Sonali M., Sureda, Anna, Fenske, Timothy S., Kharfan-Dabaja, Mohamed A., Armand, Phillipe, Hamadani, Mehdi
Publicado 2017

Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma

por Wu, Susan Y., Fang, Penny Q., Wang, Ethan B., Ahmed, Sairah, Duvic, Madeleine, Jain, Preetesh, Castillo, Luis E. Malpica, Nair, Ranjit, Steiner, Raphael E., Strati, Paolo, Huen, Auris O., Iyer, Swaminathan P., Pinnix, Chelsea C., Dabaja, Bouthaina S., Gunther, Jillian R.
Publicado 2023

An international real-world analysis of relapsed/refractory lymphoma occurring during pregnancy

por Farooq, Faheem, Brandt, Justin S., Cardonick, Elyce, Polushkina, Evgeniya, Vose, Julie, Ahmed, Sairah, Ramakrishnan Geethakumari, Praveen, Olszewski, Adam J., Yasin, Hesham, Farooq, Umar, Hamad, Nada, Lin, Yong, Maggen, Charlotte, Fruscio, Robert, Gziri, Mina Mhallem, Steffensen, Karina Dahl, Amant, Frédéric, Evens, Andrew M.
Publicado 2023

PD-L1(+) macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphoma

por Steiner, Raphael E., Parra, Edwin R., Vega, Francisco, Feng, Lei, Westin, Jason R., Neelapu, Sattva S., Strati, Paolo, Green, Michael R., Flowers, Christopher R., Solis, Luisa M., Wistuba, Ignacio I., Ahmed, Sairah, Nair, Ranjit, Hagemeister, Fredrick B., Noorani, Mansoor, Marques-Piubelli, Mario L.
Publicado 2023

Day 30 SUV(max) predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy

por Al Zaki, Ajlan, Feng, Lei, Watson, Grace, Ahmed, Sairah A., Mistry, Haleigh, Nastoupil, Loretta J., Hawkins, Misha, Nair, Ranjit, Iyer, Swaminathan P., Lee, Hun J., Steiner, Raphael E., Flowers, Christopher R., Shpall, Elizabeth J., Kebriaei, Partow, Neelapu, Sattva S., Westin, Jason R., Strati, Paolo
Publicado 2022

Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma

por Steiner, Raphael E., Banchs, Jose, Koutroumpakis, Efstratios, Becnel, Melody, Gutierrez, Cristina, Strati, Paolo, Pinnix, Chelsea C., Feng, Lei, Rondon, Gabriela, Claussen, Catherine, Palaskas, Nicolas, Karimzad, Kaveh, Ahmed, Sairah, Neelapu, Sattva S., Shpall, Elizabeth, Wang, Michael, Vega, Francisco, Westin, Jason, Nastoupil, Loretta J., Deswal, Anita
Publicado 2021

Phase 2 Clinical Trial of High-Dose Gemcitabine/Busulfan/Melphalan for Autologous Stem-Cell Transplantation in Relapsed/Refractory Myeloma: Matched-Pair Comparison with Melphalan

por Nieto, Yago, Valdez, Benigno C, Pingali, Sai R, Bassett, Roland, Delgado, Ruby, Nguyen, John, Shah, Nina, Popat, Uday, Jones, Roy B, Andersson, Borje S, Gulbis, Alison, Ahmed, Sairah, Bashir, Qaiser, Parmar, Simrit, Patel, Krina, Myers, Alan, Rondon, Gabriela, Orlowski, Robert Z, Champlin, Richard, Qazilbash, Muzaffar
Publicado 2017

Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy

por Pinnix, Chelsea C., Gunther, Jillian R., Fang, Penny, Bankston, Mikaela E, Milgrom, Sarah A., Boyce, David, Lee, Hun Ju, Nair, Ranjit, Steiner, Raphael, Strati, Paolo, Ahmed, Sairah, Iyer, Swaminathan P., Westin, Jason, Parmar, Simrit, Rodriguez, M. Alma, Nastoupil, Loretta, Neelapu, Sattva, Flowers, Christopher, Dabaja, Bouthaina S.
Publicado 2020